FDA Submits Proposed Collection of Information for Review and Clearance Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, as required by the Paperwork Reduction Act of 1995, to establish a registration and listing process for human cells, tissues, and cellular and tissue-based products, and to determine donor eligibility.